Literature DB >> 22489623

Effect of hypertrophic cardiomyopathy-linked troponin C mutations on the response of reconstituted thin filaments to calcium upon troponin I phosphorylation.

Acchia N J Albury1, Nicholas Swindle, Darl R Swartz, Svetlana B Tikunova.   

Abstract

The objective of this work was to investigate the effect of hypertrophic cardiomyopathy-linked A8V and E134D mutations in cardiac troponin C (cTnC) on the response of reconstituted thin filaments to calcium upon phosphorylation of cardiac troponin I (cTnI) by protein kinase A. The phosphorylation of cTnI at protein kinase A sites was mimicked by the S22D/S23D double mutation in cTnI. Our results demonstrate that the A8V and E134D mutations had no effect on the extent of calcium desensitization of reconstituted thin filaments induced by cTnI pseudophosphorylation. However, the A8V mutation enhanced the effect of cTnI pseudophosphorylation on the rate of dissociation of calcium from reconstituted thin filaments and on the calcium dependence of actomyosin ATPase. Consequently, while the A8V mutation still led to a slower rate of dissociation of calcium from reconstituted thin filaments upon pseudophosphorylation of cTnI, the ability of the A8V mutation to decrease the rate of calcium dissociation was weakened. In addition, the ability of the A8V mutation to sensitize actomyosin ATPase to calcium was weakened after cTnI was replaced by the phosphorylation mimetic of cTnI. Consistent with the hypothesis that the E134D mutation is benign, it exerted a minor to no effect on the rate of dissociation of calcium from reconstituted thin filaments or on the calcium sensitivity of actomyosin ATPase, regardless of the cTnI phosphorylation status. In conclusion, our study enhances our understanding of how cardiomyopathy-linked cTnC mutations affect the response of reconstituted thin filaments to calcium upon cTnI phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22489623      PMCID: PMC3341542          DOI: 10.1021/bi300187k

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  The amino acid sequence of bovine cardiac tamponin-C. Comparison with rabbit skeletal troponin-C.

Authors:  J P van Eerd; K Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1975-05-05       Impact factor: 3.575

2.  A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity.

Authors:  Z B Yu; L F Zhang; J P Jin
Journal:  J Biol Chem       Date:  2001-02-08       Impact factor: 5.157

Review 3.  Phenotypic diversity in hypertrophic cardiomyopathy.

Authors:  Michael Arad; J G Seidman; Christine E Seidman
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

4.  Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic function.

Authors:  John C Barbato; Qi-Quan Huang; M Moazzem Hossain; Meredith Bond; Jian-Ping Jin
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

5.  Determinants of relaxation rate in rabbit skinned skeletal muscle fibres.

Authors:  Ye Luo; Jonathan P Davis; Lawrence B Smillie; Jack A Rall
Journal:  J Physiol       Date:  2002-12-15       Impact factor: 5.182

6.  Structure of cardiac muscle troponin C unexpectedly reveals a closed regulatory domain.

Authors:  S K Sia; M X Li; L Spyracopoulos; S M Gagné; W Liu; J A Putkey; B D Sykes
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

7.  Effect of hydrophobic residue substitutions with glutamine on Ca(2+) binding and exchange with the N-domain of troponin C.

Authors:  Svetlana B Tikunova; Jack A Rall; Jonathan P Davis
Journal:  Biochemistry       Date:  2002-05-28       Impact factor: 3.162

Review 8.  Molecular genetics of familial hypertrophic cardiomyopathy (FHC).

Authors:  Murali D Bashyam; Gorinabele R Savithri; Murugapiran S Kumar; Calambur Narasimhan; Pratibha Nallari
Journal:  J Hum Genet       Date:  2003       Impact factor: 3.172

9.  The effects of N helix deletion and mutant F29W on the Ca2+ binding and functional properties of chicken skeletal muscle troponin.

Authors:  M Chandra; E F da Silva; M M Sorenson; J A Ferro; J R Pearlstone; B E Nash; T Borgford; C M Kay; L B Smillie
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

Review 10.  The troponin complex and regulation of muscle contraction.

Authors:  C S Farah; F C Reinach
Journal:  FASEB J       Date:  1995-06       Impact factor: 5.191

View more
  12 in total

1.  Molecular and functional consequences of mutations in the central helix of cardiac troponin C.

Authors:  Nicholas Swindle; Acchia N J Albury; Belal Baroud; Maryam Burney; Svetlana B Tikunova
Journal:  Arch Biochem Biophys       Date:  2014-03-17       Impact factor: 4.013

2.  Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.

Authors:  Henry G Zot; Javier E Hasbun; Clara A Michell; Maicon Landim-Vieira; Jose R Pinto
Journal:  Arch Biochem Biophys       Date:  2016-03-11       Impact factor: 4.013

3.  S-Nitrosylation of Calcium-Handling Proteins in Cardiac Adrenergic Signaling and Hypertrophy.

Authors:  Tomoya Irie; Patrick Y Sips; Shinichi Kai; Kotaro Kida; Kohei Ikeda; Shuichi Hirai; Kasra Moazzami; Pawina Jiramongkolchai; Donald B Bloch; Paschalis-Thomas Doulias; Antonis A Armoundas; Masao Kaneki; Harry Ischiropoulos; Evangelia Kranias; Kenneth D Bloch; Jonathan S Stamler; Fumito Ichinose
Journal:  Circ Res       Date:  2015-08-10       Impact factor: 17.367

Review 4.  Biochemical characterisation of Troponin C mutations causing hypertrophic and dilated cardiomyopathies.

Authors:  Athanasia Kalyva; Fragiskos I Parthenakis; Maria E Marketou; Joanna E Kontaraki; Panos E Vardas
Journal:  J Muscle Res Cell Motil       Date:  2014-04-18       Impact factor: 2.698

5.  In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.

Authors:  Adriano S Martins; Michelle S Parvatiyar; Han-Zhong Feng; J Martijn Bos; David Gonzalez-Martinez; Milica Vukmirovic; Rajdeep S Turna; Marcos A Sanchez-Gonzalez; Crystal-Dawn Badger; Diego A R Zorio; Rakesh K Singh; Yingcai Wang; J-P Jin; Michael J Ackerman; Jose R Pinto
Journal:  Circ Cardiovasc Genet       Date:  2015-08-24

Review 6.  Structure and function of cardiac troponin C (TNNC1): Implications for heart failure, cardiomyopathies, and troponin modulating drugs.

Authors:  Monica X Li; Peter M Hwang
Journal:  Gene       Date:  2015-07-29       Impact factor: 3.688

Review 7.  Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

Authors:  Yuanhua Cheng; Michael Regnier
Journal:  Arch Biochem Biophys       Date:  2016-02-04       Impact factor: 4.013

8.  Knock-in mice harboring a Ca(2+) desensitizing mutation in cardiac troponin C develop early onset dilated cardiomyopathy.

Authors:  Bradley K McConnell; Sonal Singh; Qiying Fan; Adriana Hernandez; Jesus P Portillo; Peter J Reiser; Svetlana B Tikunova
Journal:  Front Physiol       Date:  2015-08-27       Impact factor: 4.566

Review 9.  Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype.

Authors:  Mayra de A Marques; Guilherme A P de Oliveira
Journal:  Front Physiol       Date:  2016-09-23       Impact factor: 4.566

10.  Inherited cardiomyopathies caused by troponin mutations.

Authors:  Qun-Wei Lu; Xiao-Yan Wu; Sachio Morimoto
Journal:  J Geriatr Cardiol       Date:  2013-03       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.